(Q33817721)

29 July 2017

Cost utility of drugs for multiple sclerosis. Systematic review places study in contrast (English)

1 reference

29 July 2017

J Bryant

1

1 reference

PubMed ID

10877569

29 July 2017

A Clegg

series ordinal

2

1 reference

PubMed ID

10877569

29 July 2017

R Milne

series ordinal

3

1 reference

PubMed ID

10877569

29 July 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

29 July 2017

1 reference

29 July 2017

320

1 reference

29 July 2017

1474-5; author reply 1475-6

1 reference

29 July 2017

7247

1 reference

Population based cost utility study of interferon beta-1b in secondary progressive multiple sclerosis

29 July 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1127655

Gains in life expectancy from medical interventions--standardizing data on outcomes

4 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1127655

Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential i

4 July 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1127655

Sleep apnoea and the misuse of evidence-based medicine

4 July 2018

1 reference

12 December 2020

Problems of using modelling in the economic evaluation of health care

1 reference

12 December 2020

Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS

1 reference

12 December 2020

A cost-utility analysis of interferon beta for multiple sclerosis

1 reference

12 December 2020

10.1136/BMJ.320.7247.1474

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference